Xiaoting Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer-related molecular mechanisms research 13
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Pulmonary Hypertension Research and Treatments 2
- Vasculitis and related conditions 2
- Co-authors
- Baosen Zhou (15 shared papers)Zhihua Yin (15 shared papers)Qicai Liu (14 shared papers)Zhigang Cui (13 shared papers)Zhong-Hai Zhou (4 shared papers)Junquan Liu (3 shared papers)Shengli Wang (11 shared papers)Juan Li (10 shared papers)
- Journals
- International Immunopharmacology (4 papers)Genes and Immunity (3 papers)DNA and Cell Biology (3 papers)Cancer Management and Research (2 papers)Cancer Cell International (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoting Lv
41 papers receiving 630 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 196
- Toxicology 23
- Internal Medicine 10
- Pulmonary and Respiratory Medicine 87
- Molecular Biology 142
Countries citing papers authored by Xiaoting Lv
This map shows the geographic impact of Xiaoting Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Lv more than expected).
Fields of papers citing papers by Xiaoting Lv
This network shows the impact of papers produced by Xiaoting Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Lv. The network helps show where Xiaoting Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 79 | |
| 2 | 2022 | 60 | |
| 3 | 2021 | 37 | |
| 4 | 2015 | 35 | |
| 5 | 2016 | 29 | |
| 6 | 2018 | 29 | |
| 7 | 2018 | 29 | |
| 8 | 2016 | 28 | |
| 9 | 2018 | 28 | |
| 10 | 2020 | 28 | |
| 11 | 2018 | 19 | |
| 12 | 2018 | 19 | |
| 13 | 2019 | 19 | |
| 14 | 2015 | 16 | |
| 15 | 2018 | 16 | |
| 16 | 2019 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2022 | 15 | |
| 19 | 2020 | 13 | |
| 20 | 2017 | 12 |
About Xiaoting Lv
Xiaoting Lv is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Infectious Diseases, Rheumatology and Immunology, having authored 42 papers that have together received 641 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), COVID-19 Clinical Research Studies (3 papers), Pulmonary Hypertension Research and Treatments (2 papers), Vasculitis and related conditions (2 papers), Mitochondrial Function and Pathology (2 papers), Immune Cell Function and Interaction (2 papers) and Genetic Associations and Epidemiology (2 papers). The work is most often cited by research in Cancer Research (196 citations), Toxicology (23 citations), Internal Medicine (10 citations), Pulmonary and Respiratory Medicine (87 citations) and Molecular Biology (142 citations). Xiaoting Lv has collaborated with scholars based in China and United States. Frequent co-authors include Baosen Zhou, Zhihua Yin, Qicai Liu, Zhigang Cui, Zhong-Hai Zhou, Junquan Liu, Shengli Wang, Juan Li, Min Gao and Sheng Zhang. Their work appears in journals such as International Immunopharmacology, Genes and Immunity, DNA and Cell Biology, Cancer Management and Research and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.